Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis.

Palazzo L, Clarelli F, Giordano A, Ferré L, Moiola L, Rocca MA, Esposito F, Filippi M, Clinical SanRaf MS Study Group.

Open source

DOI
10.1007/s00415-026-14171-8
Published
2026-10-05
Container
J Neurol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00415-026-14171-8,
  title = {Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis.},
  author = {Palazzo L and  Clarelli F and  Giordano A and  Ferré L and  Moiola L and  Rocca MA and  Esposito F and  Filippi M and  Clinical SanRaf MS Study Group.},
  year = {2026},
  journal = {J Neurol},
  doi = {10.1007/s00415-026-14171-8},
  url = {https://doi.org/10.1007/s00415-026-14171-8}
}

RIS

TY  - JOUR
TI  - Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis.
AU  - Palazzo L
AU  -  Clarelli F
AU  -  Giordano A
AU  -  Ferré L
AU  -  Moiola L
AU  -  Rocca MA
AU  -  Esposito F
AU  -  Filippi M
AU  -  Clinical SanRaf MS Study Group.
PY  - 2026
JO  - J Neurol
DO  - 10.1007/s00415-026-14171-8
UR  - https://doi.org/10.1007/s00415-026-14171-8
ER  - 

APA

L, P., F, C., A, G., L, F., L, M., MA, R., F, E., M, F., & Group., C. S. M. S. (2026). Incidence of Progression Independent of Relapse Activity (PIRA) under platform disease-modifying treatment in multiple sclerosis.. J Neurol. https://doi.org/10.1007/s00415-026-14171-8

Source records